This study aims to investigate the effects of obstructive sleep apnea (OSA) on executive function and empathy development in children aged 3-12 years. The study will compare the outcomes of different treatment approaches (surgical vs. pharmacological) in children with mild OSA and track the progression of cognitive and emotional functions over 12 months. The study will also explore potential EEG biomarkers for assessing neurological damage in OSA children.
Age range
3 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Executive function measured by the "Heart and Flower" task.
Timeframe: Baseline, 6 months, and 12 months
Empathy Level Measured by the Pain Empathy Paradigm
Timeframe: Baseline, 6 months, and 12 months
Parent-Reported Executive Function Using BRIEF-P Questionnaire
Timeframe: Baseline, 6 months, and 12 months
Working Memory Assessed by WPPSI-IV or WISC-IV
Timeframe: Baseline, 6 months, and 12 months